SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Wilkinson Michael O.

(Last) (First) (Middle)
929 N. FRONT STREET

(Street)
WILMINGTON NC 28401

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PHARMACEUTICAL PRODUCT DEVELOPMENT INC [ PPDI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Information Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/14/2011
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/14/2011 M 12,421 A $19.94 14,125 (1) D
Common Stock 02/14/2011 M 12,075 A $25.74 26,200 (1) D
Common Stock 02/14/2011 S 24,496 D $28.84 (2) 1,704 (1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (to buy) $19.94 02/14/2011 M 12,421 11/20/2009 (5) 11/20/2018 Common Stock 12,421 $0 6,211 D
Stock Options (to buy) $25.74 02/14/2011 M 12,075 02/18/2010 (9) 02/18/2019 Common Stock 12,075 $0 24,152 D
Stock Options (to buy) $26.64 06/17/2011 (3) 06/17/2020 Common Stock 15,000 15,000 D
Stock Options (to buy) $20.45 02/25/2011 (4) 02/25/2020 Common Stock 31,052 31,052 D
Stock Options (to buy) $37.69 10/03/2009 (6) 10/03/2018 Common Stock 18,632 18,632 D
Stock Options (to buy) $33.8 09/27/2008 (7) 09/27/2017 Common Stock 62,104 62,104 D
Stock Options (to buy) $43.26 02/20/2009 (8) 02/20/2018 Common Stock 7,763 7,763 D
Explanation of Responses:
1. Includes shares acquired under the automatic dividend reinvestment provision of the Company's Employee Stock Purchase Plan.
2. The price shown is a weighted average; the shares were sold at prices ranging from $28.75 to $28.92. Upon request by the Commission staff, the issuer or a security holder of the issuer, full informaiton regarding the number of shares at each separate price is available.
3. The options vest in 1/3 increments on 6/17/11, 6/17/12 and 6/17/13.
4. The options vest in 1/3 increments on 2/25/11, 2/25/12 and 2/25/13.
5. The options vest in 1/3 increments on 11/20/09, 11/20/10 and 11/20/11.
6. The options will vest in 1/3 increments on 10/8/09, 10/8/10 and 10/8/11.
7. The options vest in 1/3 increments on 9/27/08, 9/27/09 and 9/27/10.
8. The options vest in 1/3 increments on 2/20/09, 2/20/10 and 2/20/11.
9. The options vest in 1/3 increments on 2/18/10, 2/18/12 and 2/18/12.
Remarks:
Lisa C. Noecker attorney-in-fact for Michael O. Wilkinson 02/14/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.